Long-term efficacy and safety of difelikefalin in moderate-to-severe pruritus in Japanese hemodialysis patients: a 52-week open-label extension period of a phase 3 trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Renal Replacement Therapy

Topics

Medicine

Pathology

Physiology

Dermatology

Internal Medicine

Show all topics

DOI

10.1186/s41100-024-00557-9

License

CC-BY

Other Formats

PDF